DaVita Inc. to Participate in Fireside Chat with Wolfe Research
DaVita (NYSE: DVA) said its chief financial officer, Joel Ackerman, will take part in a fireside chat at the Wolfe Research Healthcare Conference on Monday, November 17, 2025 at 11:20 am ET.
Investors can watch a live webcast via Wolfe Research with free registration. As of September 30, 2025, DaVita served approximately 293,200 patients at 3,247 outpatient dialysis centers—2,662 in the United States and 585 across 14 other countries.
The company describes itself as a comprehensive kidney care provider focused on clinical quality and transforming care delivery.
DaVita (NYSE: DVA) ha detto che il suo direttore finanziario, Joel Ackerman, parteciperà a una chiacchierata informale al Wolfe Research Healthcare Conference lunedì 17 novembre 2025 alle ore 11:20 am ET.
I investitori possono seguire una trasmissione web in diretta via Wolfe Research con registrazione gratuita. Al 30 settembre 2025, DaVita serviva circa 293.200 pazienti in 3.247 centri di dialisi ambulatori—2.662 negli Stati Uniti e 585 in altre 14 nazioni.
L'azienda si descrive come un fornitore completo di cure renali focalizzato sulla qualità clinica e sulla trasformazione dell'erogazione delle cure.
DaVita (NYSE: DVA) dijo que su director financiero, Joel Ackerman, participará en una charla informal en la Wolfe Research Healthcare Conference el lunes 17 de noviembre de 2025 a las 11:20 a. m. hora del Este.
Los inversores pueden ver una transmisión en vivo a través de Wolfe Research con registro gratuito. A partir del 30 de septiembre de 2025, DaVita atendía aproximadamente a 293.200 pacientes en 3.247 centros de diálisis ambulatoria—2.662 en Estados Unidos y 585 en 14 países más.
La empresa se describe a sí misma como un proveedor integral de cuidado renal centrado en la calidad clínica y en transformar la entrega de la atención.
DaVita (NYSE: DVA)는 최고재무책임자 Joel Ackerman가 2025년 11월 17일 월요일 동부표준시 11:20에 Wolfe Research Healthcare Conference에서 파이어사이드 채팅에 참여할 것이라고 밝혔다.
투자자들은 Wolfe Research를 통해 무료 등록으로 라이브 웹캐스트를 시청할 수 있다. 2025년 9월 30일 기준, DaVita는 약 293,200명의 환자를 3,247개의 외래 투석 센터에서 치료했고—미합중국에 2,662명과 14개국에서 585명이다.
회사는 자신을 임상 품질과 치료 전달의 변혁에 중점을 둔 포괄적인 신장 관리 공급자로 설명한다.
DaVita (NYSE: DVA) a déclaré que son directeur financier, Joel Ackerman, participera à une table ronde (fireside chat) lors de la Wolfe Research Healthcare Conference le lundi 17 novembre 2025 à 11h20 EDT.
Les investisseurs peuvent regarder une diffusion en direct via Wolfe Research avec une inscription gratuite. Au 30 septembre 2025, DaVita desservait environ 293 200 patients dans 3 247 centres de dialyse ambulatoire—2 662 aux États‑Unis et 585 dans 14 autres pays.
L'entreprise se décrit comme un fournisseur global de soins rénaux axé sur la qualité clinique et la transformation de la prestation des soins.
DaVita (NYSE: DVA) gab bekannt, dass sein Chief Financial Officer, Joel Ackerman, an einem Fireside-Chat bei der Wolfe Research Healthcare Conference teilnehmen wird, am Montag, dem 17. November 2025 um 11:20 Uhr ET.
Investoren können eine Live-Webcast über Wolfe Research mit kostenloser Registrierung verfolgen. Stand 30. September 2025 betreute DaVita etwa 293.200 Patienten in 3.247 Ambulanz-Dialysezentren—2.662 in den USA und 585 in 14 weiteren Ländern.
Das Unternehmen beschreibt sich selbst als umfassenden Kidney-Care-Anbieter, der sich auf klinische Qualität und die Transformation der Versorgung konzentriert.
DaVita (NYSE: DVA) قالت إن مديرها المالي، Joel Ackerman، سيشارك في حديث أمام المدفأة (fireside chat) في Wolfe Research Healthcare Conference في الاثنين 17 نوفمبر 2025 الساعة 11:20 صباحاً بتوقيت شرق الولايات المتحدة.
يمكن للمستثمرين مشاهدة البث المباشر عبر Wolfe Research مع تسجيل مجاني. اعتباراً من 30 سبتمبر 2025، خدمـت DaVita حوالي 293,200 مريض في 3,247 مركزاً للغسيل الدموي الخارجي—2,662 في الولايات المتحدة و585 في 14 دولة أخرى.
وتصف الشركة نفسها بأنها مزود رعاية كلوية شامل يركز على الجودة السريرية وتحويل تقديم الرعاية.
- None.
- None.
About DaVita Inc.
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for 25 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of September 30, 2025, DaVita served approximately 293,200 patients at 3,247 outpatient dialysis centers, of which 2,662 centers were located in the United States and 585 centers were located in 14 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, helped improve health access and worked collaboratively to propel the kidney care community to adopt a higher quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.
Contact Information
IR@davita.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-inc-to-participate-in-fireside-chat-with-wolfe-research-302616071.html
SOURCE DaVita
FAQ
When will DaVita (DVA) participate in the Wolfe Research Healthcare Conference?
How can investors watch DaVita (DVA) fireside chat on November 17, 2025?
What patient and center metrics did DaVita (DVA) report as of September 30, 2025?
Who will represent DaVita (DVA) at the Wolfe Research Healthcare Conference?
Is there a cost to view DaVita's (DVA) Wolfe Research fireside chat webcast?
